MyFinsight
Home
Blog
About
Contact
Proceeds from the
issuance of shares, net of...
$27,874,441
Total cash flow from
financing activities
$27,874,441
Increase (decrease) in
cash and cash...
-$3,613,587
Canceled cashflow
$27,874,441
Share-based compensation
$1,012,749
Increase in accrued
expenses and other...
$721,774
Share of loss on equity
investment
-$171,126
Depreciation
$74,871
Amortization
$11,453
Proceeds from short-term
investments
$7,372,473
Total cash flow from
operating activities
-$22,692,452
Canceled cashflow
$1,991,973
Total cash flow from
investing activities
-$8,795,576
Canceled cashflow
$7,372,473
Net loss for the
period
-$22,812,276
Decrease in accounts
payable
-$1,109,266
Change in fair value of
the warrant...
-$265,818
Increase (decrease) in
amounts receivable and...
-$216,031
Financial income, net
$143,204
Unrealized gain on
investment
$137,830
Purchase of short-term
investments
$15,781,000
Equity investment in bc
therapeutics
$260,000
Purchase of equipment
$127,049
Back
Back
Cash Flow
BriaCell Therapeutics Corp. (BCTXL)
BriaCell Therapeutics Corp. (BCTXL)
source: myfinsight.com